原发性中枢神经系统边缘区淋巴瘤
本文综述原发性中枢神经系统边缘区淋巴瘤(PCNSMZL)的表现、鉴别诊断、病理、治疗与结局;已发表207例,多为个案或小系列,标准治疗尚未确定,不同治疗后预后均良好,但需权衡过度治疗风险,随访短是主要局限。
要点
- PCNSMZL多表现为轴外硬脑膜肿块,影像学易误诊为脑膜瘤。
- 病理为CD20+、CD3-小B淋巴细胞,可伴浆细胞分化,增殖指数低。
- 3号染色体三体常见,MALT1或IgH易位不常见,TNFAIP3和NOTCH2为复发性异常。
核心结论
- PCNSMZL标准治疗尚未确定,手术、放疗、化疗或其组合后预后均良好,但每种治疗需在准确评估过度治疗风险后考虑。
研究设计与样本
- 综述,聚焦PCNSMZL的表现、鉴别诊断、病理发现、治疗选择与临床结局,并提供最佳临床实践建议;截至本文已发表207例,多为单病例报告或小病例系列。
主要发现
- PCNSMZL最常表现为轴外硬脑膜肿块,更多见于中年女性,起病隐匿,诊断前症状史长。
- 影像学上PCNSMZL可被误诊为脑膜瘤。
- PCNSMZL由CD20+、CD3-小B淋巴细胞组成,伴不同程度浆细胞分化和低增殖指数。
- 3号染色体三体是常见遗传学异常,而MALT1或IgH易位不常见;其他复发性遗传学异常涉及TNFAIP3和NOTCH2。
- 病因与发病机制研究较少。
关键数值与推荐
- 已发表PCNSMZL病例共207例。
- PCNSMZL由CD20+、CD3-小B淋巴细胞组成,伴不同程度浆细胞分化和低增殖指数。
- 3号染色体三体常见,MALT1或IgH易位不常见,复发性遗传学异常涉及TNFAIP3和NOTCH2。
临床怎么用
- 作者综述中提供最佳临床实践建议,但标准治疗尚未确定。
- 手术、放疗、化疗或其组合等不同治疗后预后均良好。
- 每种治疗应在准确分析过度治疗风险后考虑。
局限性
- 已报告PCNSMZL病例随访短是主要局限,限制了对长期结果和医源性后遗症的认识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Marginal zone lymphoma (MZL) is the most common indolent lymphoma primarily arising in the central nervous system (CNS). To date, 207 cases of primary CNS MZL (PCNSMZL) were published, mostly as single case reports or small case series. It most commonly presents as extra-axial dural-based masses, more frequently in middle-aged women, displaying an insidious onset, with a long history of symptoms preceding the diagnosis. PCNSMZL can be radiographically mistaken for meningioma. PCNSMZL consists of CD20+ , CD3- small B lymphocytes with varying degrees of plasmacytic differentiation and low proliferation index. Trisomy 3, but not MALT1 or IgH translocation, is a common genetic abnormality. Other recurrent genetic abnormalities involve TNFAIP3 and NOTCH2. Ethiopathogenesis was poorly investigated. Due to its rarity, standard of care remains to be defined; it exhibits an excellent prognosis after varied treatments, such as surgery, radiotherapy, chemotherapy or their combinations. Nevertheless, each treatment should be considered after an accurate analysis of overtreatment risk. Short follow-up is a major limitation in reported PCNSMZL cases, which restrains our knowledge on long-term results and iatrogenic sequels. This review was focussed on presentation, differential diagnoses, pathological findings, treatment options and clinical outcomes of PCNSMZL; recommendations for best clinical practice are provided.
引用
- Flospergher E, Marino F, Calimeri T, et al. Primary central nervous system marginal zone lymphoma. Br J Haematol. 2023. PMID: 38054330. doi:10.1111/bjh.19238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。